Literature DB >> 16320156

Mild congenital primary hypothyroidism in a Turkish family caused by a homozygous missense thyrotropin receptor (TSHR) gene mutation (A593 V).

S Fricke-Otto1, N Pfarr, R Mühlenberg, J Pohlenz.   

Abstract

Congenital primary hypothyroidism (CH) occurs in 1 of 4000 births. The majority of the cases are due to agenesis or dysgenesis of the thyroid gland, which can be caused by mutations in genes encoding for transcriptional factors that are responsible for the development of the thyroid gland. It is also known that the thyrotropin receptor (TSHR), a G-protein coupled receptor, is involved in late stages of thyroid organogenesis. Thus, mutations in the TSHR gene can cause congenital hypothyroidism. However, the clinical spectrum of thyroid abnormalities due to mutant TSHRs is wide and ranges from severe hypoplasia to an almost normal sized and structured thyroid gland. So far, 23 distinct loss-of-function mutations in the TSHR gene have been reported, occurring in families of different ethnic backgrounds and geographical areas. Here we report on a Turkish kindred in which two children were diagnosed to have very mild congenital primary hypothyroidism and one child had subclinical hypothyroidism. A novel homozygous missense mutation in codon 593 (A593 V) of the TSHR gene was identified in the affected individuals as the underlying molecular defect. This mutation substitutes a non-polar amino acid (alanine) with a non-polar amino acid (valine), so that only a minimal impairment of the TSHR function is expected. Indeed, the molecular finding is in agreement with the observed mild phenotype of the affected individuals. Our conclusion is that in mild primary hypothyroidism or subclinical hypothyroidism, mutations in the TSHR gene have to be considered as the molecular cause, especially in patients who have no detectable thyroid autoantibodies and have thyroid glands of normal size and in normal location.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16320156     DOI: 10.1055/s-2005-865914

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

Review 1.  The molecular causes of thyroid dysgenesis: a systematic review.

Authors:  I C Nettore; V Cacace; C De Fusco; A Colao; P E Macchia
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

Review 2.  Resistance to thyrotropin.

Authors:  Helmut Grasberger; Samuel Refetoff
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2017-03-30       Impact factor: 4.690

3.  From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs).

Authors:  Gunnar Kleinau; Inna Hoyer; Annika Kreuchwig; Ann-Karin Haas; Claudia Rutz; Jens Furkert; Catherine L Worth; Gerd Krause; Ralf Schülein
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

Review 4.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

Review 5.  Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications.

Authors:  Shan Jin; Oyungerel Borkhuu; Wuyuntu Bao; Yun-Tian Yang
Journal:  J Clin Med Res       Date:  2016-02-27

6.  Congenital Hypothyroidism Patients With Thyroid Hormone Receptor Variants Are Not Rare: A Systematic Review.

Authors:  Dong-Zhu Da; Ye Wang; Min Wang; Zhi Long; Qian Wang; Jun Liu
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

Review 7.  Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment.

Authors:  Alessandra Cassio; Annalisa Nicoletti; Angela Rizzello; Emanuela Zazzetta; Milva Bal; Lilia Baldazzi
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-15

8.  Clinical significance of heterozygous carriers associated with compensated hypothyroidism in R450H, a common inactivating mutation of the thyrotropin receptor gene in Japanese.

Authors:  Keisuke Kanda; Haruo Mizuno; Yukari Sugiyama; Hiroki Imamine; Hajime Togari; Kazumichi Onigata
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.